Patents by Inventor Bin Shao

Bin Shao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl substituted pyridines and the use thereof
    Patent number: 7105549
    Abstract: This invention relates aryl substituted pyridines of Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Ar and R1–R4 are set in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: September 12, 2006
    Assignee: Euro-Celtique S.A.
    Inventors: Bin Shao, R. Richard Goehring, Samuel F Victory, Qun Sun
  • Aryl substituted pyrimidines
    Patent number: 6867210
    Abstract: This invention relates aryl substituted pyridines, pyrimidines, pyrazines and triazines of Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein A1, A2, A3, R1-R4, X and Y are set in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: March 15, 2005
    Assignee: Euro-Celtique S.A.
    Inventors: Derk J. Hogenkamp, Phong Nguyen, Bin Shao
  • Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
    Publication number: 20050043305
    Abstract: This invention relates aryl substituted pyridines, pyrimidines, pyrazines and triazines of Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein A1, A2, A3, R1—R4, X and Y are set in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
    Type: Application
    Filed: September 29, 2004
    Publication date: February 24, 2005
    Applicant: Euro-Celtique S.A.
    Inventors: Derk Hogenkamp, Phong Nguyen, Bin Shao
  • Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
    Publication number: 20040192691
    Abstract: This invention relates aryl substituted pyridines, pyrimidines, pyrazines and triazines of Formula I: 1
    Type: Application
    Filed: December 19, 2003
    Publication date: September 30, 2004
    Applicant: Euro-Celtique S.A.
    Inventors: Derk J. Hogenkamp, Phong Nguyen, Bin Shao
  • Aryl substituted pyridines and their use
    Patent number: 6770661
    Abstract: This invention relates to aryl substituted pyridines of Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Ar and R1-R4 are set in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, including diabetic neuropathy, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, and as antiarrhythmics.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: August 3, 2004
    Assignee: Euro-Celtique S.A.
    Inventors: Bin Shao, R. Richard Goehring
  • Aryl substituted pyridines and their use
    Publication number: 20030073724
    Abstract: This invention relates to aryl substituted pyridines of Formula I: 1
    Type: Application
    Filed: September 6, 2002
    Publication date: April 17, 2003
    Inventors: Bin Shao, R. Richard Goehring
  • Aryl substituted pyridines and the use thereof
    Publication number: 20030055088
    Abstract: This invention relates aryl substituted pyridines of Formula I: 1
    Type: Application
    Filed: September 6, 2002
    Publication date: March 20, 2003
    Applicant: Euro-Celtique S.A.
    Inventors: Bin Shao, R. Richard Goehring, Samuel F. Victory, Qun Sun
  • Benzimidazole compounds having nociceptin receptor affinity
    Publication number: 20020128288
    Abstract: Disclosed are compounds of the formula (I) 1
    Type: Application
    Filed: December 6, 2000
    Publication date: September 12, 2002
    Inventors: Donald Kyle, R. Richard Goehring, Bin Shao
  • Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
    Publication number: 20020040025
    Abstract: This invention relates aryl substituted pyridines, pyrimidines, pyrazines and triazines of Formula I: 1
    Type: Application
    Filed: March 12, 2001
    Publication date: April 4, 2002
    Inventors: Derk J. Hogenkamp, Phong Nguyen, Bin Shao